시장조사 보고서 : 세계의 폐렴구균 백신 시장예측 2021년-2026년

■ 영문 제목 : Global Pneumococcal Bacteria Vaccine Market Growth 2021-2026
	■ 상품코드 : LPI-2201K02154 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 92 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 폐렴구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (PPSV 23, PCV 13, PCV 10)와 용도별 시장규모 (유아, 아동, 성인) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 폐렴구균 백신 시장 점유율
- 지역별 폐렴구균 백신 시장규모
- 주요지역의 종류별 시장규모 (PPSV 23, PCV 13, PCV 10)
- 주요지역의 용도별 시장규모 (유아, 아동, 성인)
- 미주의 폐렴구균 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 폐렴구균 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 폐렴구균 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 폐렴구균 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 폐렴구균 백신 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Merck, Sanofi, Sinopharm, Pfizer, Walvax, GSK
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Pneumococcal Bacteria Vaccine will have significant change from previous year. By the most conservative estimates of global Pneumococcal Bacteria Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Pneumococcal Bacteria Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Bacteria Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
PPSV 23
PCV 13
PCV 10

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Infant
Children
Adult

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merck
Sanofi
Sinopharm
Pfizer
Walvax
GSK

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pneumococcal Bacteria Vaccine Consumption 2016-2026
2.1.2 Pneumococcal Bacteria Vaccine Consumption CAGR by Region
2.2 Pneumococcal Bacteria Vaccine Segment by Type
2.2.1 PPSV 23
2.2.2 PCV 13
2.2.3 PCV 10
2.3 Pneumococcal Bacteria Vaccine Sales by Type
2.3.1 Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Pneumococcal Bacteria Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Pneumococcal Bacteria Vaccine Sale Price by Type (2016-2021)
2.4 Pneumococcal Bacteria Vaccine Segment by Application
2.4.1 Infant
2.4.2 Children
2.4.3 Adult
2.5 Pneumococcal Bacteria Vaccine Sales by Application
2.5.1 Global Pneumococcal Bacteria Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Pneumococcal Bacteria Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Pneumococcal Bacteria Vaccine Sale Price by Application (2016-2021)

3 Global Pneumococcal Bacteria Vaccine by Company
3.1 Global Pneumococcal Bacteria Vaccine Sales Market Share by Company
3.1.1 Global Pneumococcal Bacteria Vaccine Sales by Company (2019-2021)
3.1.2 Global Pneumococcal Bacteria Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Company
3.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Company (2019-2021)
3.2.2 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Pneumococcal Bacteria Vaccine Sale Price by Company
3.4 Global Manufacturers Pneumococcal Bacteria Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pneumococcal Bacteria Vaccine Product Location Distribution
3.4.2 Players Pneumococcal Bacteria Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Pneumococcal Bacteria Vaccine by Region
4.1 Global Pneumococcal Bacteria Vaccine by Region
4.1.1 Global Pneumococcal Bacteria Vaccine Sales by Region
4.1.2 Global Pneumococcal Bacteria Vaccine Revenue by Region
4.2 Americas Pneumococcal Bacteria Vaccine Sales Growth
4.3 APAC Pneumococcal Bacteria Vaccine Sales Growth
4.4 Europe Pneumococcal Bacteria Vaccine Sales Growth
4.5 Middle East & Africa Pneumococcal Bacteria Vaccine Sales Growth

5 Americas
5.1 Americas Pneumococcal Bacteria Vaccine Sales by Country
5.1.1 Americas Pneumococcal Bacteria Vaccine Sales by Country (2016-2021)
5.1.2 Americas Pneumococcal Bacteria Vaccine Revenue by Country (2016-2021)
5.2 Americas Pneumococcal Bacteria Vaccine Sales by Type
5.3 Americas Pneumococcal Bacteria Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Pneumococcal Bacteria Vaccine Sales by Region
6.1.1 APAC Pneumococcal Bacteria Vaccine Sales by Region (2016-2021)
6.1.2 APAC Pneumococcal Bacteria Vaccine Revenue by Region (2016-2021)
6.2 APAC Pneumococcal Bacteria Vaccine Sales by Type
6.3 APAC Pneumococcal Bacteria Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Pneumococcal Bacteria Vaccine by Country
7.1.1 Europe Pneumococcal Bacteria Vaccine Sales by Country (2016-2021)
7.1.2 Europe Pneumococcal Bacteria Vaccine Revenue by Country (2016-2021)
7.2 Europe Pneumococcal Bacteria Vaccine Sales by Type
7.3 Europe Pneumococcal Bacteria Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Pneumococcal Bacteria Vaccine by Country
8.1.1 Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Pneumococcal Bacteria Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Type
8.3 Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pneumococcal Bacteria Vaccine Distributors
10.3 Pneumococcal Bacteria Vaccine Customer

11 Global Pneumococcal Bacteria Vaccine Market Forecast
11.1 Global Pneumococcal Bacteria Vaccine Forecast by Region
11.1.1 Global Pneumococcal Bacteria Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Pneumococcal Bacteria Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Pneumococcal Bacteria Vaccine Forecast by Type
11.7 Global Pneumococcal Bacteria Vaccine Forecast by Application

12 Key Players Analysis
12.1 Merck
12.1.1 Merck Company Information
12.1.2 Merck Pneumococcal Bacteria Vaccine Product Offered
12.1.3 Merck Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merck Main Business Overview
12.1.5 Merck Latest Developments
12.2 Sanofi
12.2.1 Sanofi Company Information
12.2.2 Sanofi Pneumococcal Bacteria Vaccine Product Offered
12.2.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sanofi Main Business Overview
12.2.5 Sanofi Latest Developments
12.3 Sinopharm
12.3.1 Sinopharm Company Information
12.3.2 Sinopharm Pneumococcal Bacteria Vaccine Product Offered
12.3.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Sinopharm Main Business Overview
12.3.5 Sinopharm Latest Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Pneumococcal Bacteria Vaccine Product Offered
12.4.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Pfizer Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Walvax
12.5.1 Walvax Company Information
12.5.2 Walvax Pneumococcal Bacteria Vaccine Product Offered
12.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Walvax Main Business Overview
12.5.5 Walvax Latest Developments
12.6 GSK
12.6.1 GSK Company Information
12.6.2 GSK Pneumococcal Bacteria Vaccine Product Offered
12.6.3 GSK Pneumococcal Bacteria Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 GSK Main Business Overview
12.6.5 GSK Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. Pneumococcal Bacteria Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of PPSV 23
Table 3. Major Players of PCV 13
Table 4. Major Players of PCV 10
Table 5. Global Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 6. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2021)
Table 7. Global Pneumococcal Bacteria Vaccine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2016-2021)
Table 9. Global Pneumococcal Bacteria Vaccine Sale Price by Type (2016-2021)
Table 10. Global Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 11. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2021)
Table 12. Global Pneumococcal Bacteria Vaccine Value by Application (2016-2021)
Table 13. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2016-2021)
Table 14. Global Pneumococcal Bacteria Vaccine Sale Price by Application (2016-2021)
Table 15. Global Pneumococcal Bacteria Vaccine Sales by Company (2019-2021) & (K Units)
Table 16. Global Pneumococcal Bacteria Vaccine Sales Market Share by Company (2019-2021)
Table 17. Global Pneumococcal Bacteria Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Company (2019-2021)
Table 19. Global Pneumococcal Bacteria Vaccine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Pneumococcal Bacteria Vaccine Producing Area Distribution and Sales Area
Table 21. Players Pneumococcal Bacteria Vaccine Products Offered
Table 22. Pneumococcal Bacteria Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pneumococcal Bacteria Vaccine Sales by Region (2016-2021) (K Units)
Table 26. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2016-2021)
Table 27. Global Pneumococcal Bacteria Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2016-2021)
Table 29. Americas Pneumococcal Bacteria Vaccine Sales by Country (2016-2021) & (K Units)
Table 30. Americas Pneumococcal Bacteria Vaccine Sales Market Share by Country (2016-2021)
Table 31. Americas Pneumococcal Bacteria Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Pneumococcal Bacteria Vaccine Revenue Market Share by Country (2016-2021)
Table 33. Americas Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 34. Americas Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2021)
Table 35. Americas Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 36. Americas Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2021)
Table 37. APAC Pneumococcal Bacteria Vaccine Sales by Region (2016-2021) & (K Units)
Table 38. APAC Pneumococcal Bacteria Vaccine Sales Market Share by Region (2016-2021)
Table 39. APAC Pneumococcal Bacteria Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2016-2021)
Table 41. APAC Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 42. APAC Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2021)
Table 43. APAC Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 44. APAC Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2021)
Table 45. Europe Pneumococcal Bacteria Vaccine Sales by Country (2016-2021) & (K Units)
Table 46. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Country (2016-2021)
Table 47. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Country (2016-2021)
Table 49. Europe Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 50. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2021)
Table 51. Europe Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 52. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Pneumococcal Bacteria Vaccine
Table 62. Key Application and Potential Industries of Pneumococcal Bacteria Vaccine
Table 63. Key Challenges of Pneumococcal Bacteria Vaccine
Table 64. Key Trends of Pneumococcal Bacteria Vaccine
Table 65. Pneumococcal Bacteria Vaccine Distributors List
Table 66. Pneumococcal Bacteria Vaccine Customer List
Table 67. Global Pneumococcal Bacteria Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Pneumococcal Bacteria Vaccine Consumption Market Forecast by Region
Table 69. Global Pneumococcal Bacteria Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Pneumococcal Bacteria Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Pneumococcal Bacteria Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Pneumococcal Bacteria Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Pneumococcal Bacteria Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Pneumococcal Bacteria Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Pneumococcal Bacteria Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Pneumococcal Bacteria Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Pneumococcal Bacteria Vaccine Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Pneumococcal Bacteria Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Pneumococcal Bacteria Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Pneumococcal Bacteria Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Pneumococcal Bacteria Vaccine Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Pneumococcal Bacteria Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Pneumococcal Bacteria Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Pneumococcal Bacteria Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 87. Merck Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Pneumococcal Bacteria Vaccine Product Offered
Table 89. Merck Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Merck Main Business
Table 91. Merck Latest Developments
Table 92. Sanofi Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Pneumococcal Bacteria Vaccine Product Offered
Table 94. Sanofi Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Sinopharm Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sinopharm Pneumococcal Bacteria Vaccine Product Offered
Table 99. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Sinopharm Main Business
Table 101. Sinopharm Latest Developments
Table 102. Pfizer Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Pfizer Pneumococcal Bacteria Vaccine Product Offered
Table 104. Pfizer Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Pfizer Main Business
Table 106. Pfizer Latest Developments
Table 107. Walvax Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Walvax Pneumococcal Bacteria Vaccine Product Offered
Table 109. Walvax Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Walvax Main Business
Table 111. Walvax Latest Developments
Table 112. GSK Basic Information, Pneumococcal Bacteria Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. GSK Pneumococcal Bacteria Vaccine Product Offered
Table 114. GSK Pneumococcal Bacteria Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. GSK Main Business
Table 116. GSK Latest Developments
List of Figures
Figure 1. Picture of Pneumococcal Bacteria Vaccine
Figure 2. Pneumococcal Bacteria Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pneumococcal Bacteria Vaccine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Pneumococcal Bacteria Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Pneumococcal Bacteria Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of PPSV 23
Figure 10. Product Picture of PCV 13
Figure 11. Product Picture of PCV 10
Figure 12. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type in 2020
Figure 13. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2016-2021)
Figure 14. Pneumococcal Bacteria Vaccine Consumed in Infant
Figure 15. Global Pneumococcal Bacteria Vaccine Market: Infant (2016-2021) & (K Units)
Figure 16. Pneumococcal Bacteria Vaccine Consumed in Children
Figure 17. Global Pneumococcal Bacteria Vaccine Market: Children (2016-2021) & (K Units)
Figure 18. Pneumococcal Bacteria Vaccine Consumed in Adult
Figure 19. Global Pneumococcal Bacteria Vaccine Market: Adult (2016-2021) & (K Units)
Figure 20. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2021)
Figure 21. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application in 2020
Figure 22. Pneumococcal Bacteria Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Company in 2020
Figure 24. Global Pneumococcal Bacteria Vaccine Sales Market Share by Regions (2016-2021)
Figure 25. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region in 2020
Figure 26. Americas Pneumococcal Bacteria Vaccine Sales 2016-2021 (K Units)
Figure 27. Americas Pneumococcal Bacteria Vaccine Revenue 2016-2021 ($ Millions)
Figure 28. APAC Pneumococcal Bacteria Vaccine Sales 2016-2021 (K Units)
Figure 29. APAC Pneumococcal Bacteria Vaccine Revenue 2016-2021 ($ Millions)
Figure 30. Europe Pneumococcal Bacteria Vaccine Sales 2016-2021 (K Units)
Figure 31. Europe Pneumococcal Bacteria Vaccine Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Pneumococcal Bacteria Vaccine Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue 2016-2021 ($ Millions)
Figure 34. Americas Pneumococcal Bacteria Vaccine Sales Market Share by Country in 2020
Figure 35. Americas Pneumococcal Bacteria Vaccine Revenue Market Share by Country in 2020
Figure 36. Americas Pneumococcal Bacteria Vaccine Sales Market Share by Type in 2020
Figure 37. Americas Pneumococcal Bacteria Vaccine Sales Market Share by Application in 2020
Figure 38. United States Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Pneumococcal Bacteria Vaccine Sales Market Share by Region in 2020
Figure 43. APAC Pneumococcal Bacteria Vaccine Revenue Market Share by Regions in 2020
Figure 44. APAC Pneumococcal Bacteria Vaccine Sales Market Share by Type in 2020
Figure 45. APAC Pneumococcal Bacteria Vaccine Sales Market Share by Application in 2020
Figure 46. China Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Country in 2020
Figure 53. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Country in 2020
Figure 54. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Type in 2020
Figure 55. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Application in 2020
Figure 56. Germany Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share by Application in 2020
Figure 65. Egypt Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Pneumococcal Bacteria Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles

※본 조사보고서 [세계의 폐렴구균 백신 시장예측 2021년-2026년] (코드 : LPI-2201K02154) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 폐렴구균 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 백신 시장예측 2021년-2026년
LPI-2201K02208 / LP Information / 2021년 12월 / 본 조사보고서는 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2021 growth of Vaccine will have significant change from previous year. By the most conservative estimates of global Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next...

세계의 비강 스프레이 인플루엔자 백신 시장예측 2021년-2026년
LPI-2201K02102 / LP Information / 2021년 12월 / 본 조사보고서는 비강 스프레이 인플루엔자 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Nasal Spray Influenza Vaccine will have significant change from previous year. By the most conservative estimates of global Nasal Spray Influenza Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 종양 세포 백신 시장예측 2021년-2026년
LPI-2201K02666 / LP Information / 2021년 12월 / 본 조사보고서는 종양 세포 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Tumour-cell Vaccine will have significant change from previous year. By the most conservative estimates of global Tumour-cell Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 수두 백신 시장예측 2021년-2026년
LPI-2201K02212 / LP Information / 2021년 12월 / 본 조사보고서는 수두 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Varicella Vaccine will have significant change from previous year. By the most conservative estimates of global Varicella Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3787.8 million in 2020. Over...

세계의 SARS-Cov-2 백신 (베로셀) 시장예측 2021년-2026년
LPI-2201K02170 / LP Information / 2021년 12월 / 본 조사보고서는 SARS-Cov-2 백신 (베로셀)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of SARS-Cov-2 Vaccine (Vero Cell) will have significant change from previous year. By the most conservative estimates of global SARS-Cov-2 Vaccine (Vero Cell) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 수막구균 백신 시장예측 2021년-2026년
LPI-2201K02087 / LP Information / 2021년 12월 / 본 조사보고서는 수막구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Meningococcal Vaccine will have significant change from previous year. By the most conservative estimates of global Meningococcal Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 245.5 million in 2020. Over...